Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,199 | -14,208 | -3,082 | -4,901 | -2,667 |
| Depreciation Amortization | 3,342 | 1,640 | 6,910 | 5,229 | 3,402 |
| Income taxes - deferred | N/A | 225 | N/A | N/A | N/A |
| Accounts receivable | -1,034 | -704 | 5,670 | 3,706 | 1,862 |
| Other Working Capital | 1,493 | 404 | 3,591 | 2,480 | -5,244 |
| Other Operating Activity | 11,432 | 15,087 | 5,076 | 6,152 | 9,150 |
| Operating Cash Flow | $8,034 | $2,444 | $18,164 | $12,666 | $6,504 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94 | -87 | -414 | -53 | -45 |
| Net Acquisitions | -202 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | 397 | -98 | -144 | -30 | N/A |
| Other Investing Activity | 397 | 288 | -144 | -30 | 0 |
| Investing Cash Flow | $101 | $201 | $-558 | $-83 | $-45 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,354 | -2,814 | -16,749 | -14,087 | -10,874 |
| Other Financing Activity | -92 | -44 | -189 | -183 | -157 |
| Financing Cash Flow | $-5,446 | $-2,858 | $-16,937 | $-14,270 | $-11,030 |
| Exchange Rate Effect | 127 | 170 | -80 | 253 | 342 |
| Beginning Cash Position | 19,384 | 18,803 | 17,184 | 17,280 | 16,608 |
| End Cash Position | 22,199 | 18,759 | 17,772 | 15,846 | 12,379 |
| Net Cash Flow | $2,816 | $-43 | $588 | $-1,435 | $-4,229 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,034 | 2,444 | 18,164 | 12,666 | 6,504 |
| Capital Expenditure | -94 | -87 | -414 | -53 | -45 |
| Free Cash Flow | 7,939 | 2,358 | 17,750 | 12,613 | 6,459 |